ATE130855T1 - Antikörper gegen latente proteine von menschlichen papillomavirus, diagnostische systeme und methoden. - Google Patents
Antikörper gegen latente proteine von menschlichen papillomavirus, diagnostische systeme und methoden.Info
- Publication number
- ATE130855T1 ATE130855T1 AT89304874T AT89304874T ATE130855T1 AT E130855 T1 ATE130855 T1 AT E130855T1 AT 89304874 T AT89304874 T AT 89304874T AT 89304874 T AT89304874 T AT 89304874T AT E130855 T1 ATE130855 T1 AT E130855T1
- Authority
- AT
- Austria
- Prior art keywords
- antibodies
- proteins
- methods
- latented
- papilloma virus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19440788A | 1988-05-16 | 1988-05-16 | |
US07/323,614 US5180806A (en) | 1988-05-16 | 1989-03-13 | Polypeptides and compositions of human papillomavirus latent proteins, diagnostic systems and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE130855T1 true ATE130855T1 (de) | 1995-12-15 |
Family
ID=26889974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT89304874T ATE130855T1 (de) | 1988-05-16 | 1989-05-15 | Antikörper gegen latente proteine von menschlichen papillomavirus, diagnostische systeme und methoden. |
Country Status (10)
Country | Link |
---|---|
US (3) | US5180806A (de) |
EP (1) | EP0344940B1 (de) |
JP (1) | JP2918904B2 (de) |
AT (1) | ATE130855T1 (de) |
CA (1) | CA1341287C (de) |
DE (1) | DE68924928T2 (de) |
DK (1) | DK173264B1 (de) |
ES (1) | ES2082775T4 (de) |
GR (1) | GR3018773T3 (de) |
PT (1) | PT90574B (de) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5932412A (en) * | 1990-05-11 | 1999-08-03 | Euro-Diagnostica Ab | Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes |
SE9001705D0 (sv) * | 1990-05-11 | 1990-05-11 | Medscand Ab | Saett foer diagnostik av virusbaerande tumoerer genom immunoassay |
DK0510912T3 (da) * | 1991-04-24 | 1998-02-09 | Morinaga Milk Industry Co Ltd | Antimikrobielt peptid og antimikrobielt middel |
ATE234860T1 (de) * | 1991-07-13 | 2003-04-15 | Dade Behring Marburg Gmbh | Verwendung von hpv-16 e6 und e7-gen gewonnen peptiden für den diagnostischen zweck |
DE4123760C2 (de) * | 1991-07-18 | 2000-01-20 | Dade Behring Marburg Gmbh | Seroreaktive Bereiche auf den HPV 16 Proteinen E1 und E2 |
US5437951A (en) * | 1992-09-03 | 1995-08-01 | The United States Of America As Represented By The Department Of Health And Human Services | Self-assembling recombinant papillomavirus capsid proteins |
GB9306731D0 (en) * | 1993-03-31 | 1993-05-26 | Cancer Res Campaign Tech | Vaccines |
DE19819476C1 (de) * | 1998-04-30 | 2000-01-05 | Deutsches Krebsforsch | Polypeptid mit immunogenen Eigenschaften und veränderten biologischen Funktionen eines Proteins |
GB2353581B (en) | 1999-08-27 | 2003-06-11 | Uponor Ltd | Swage lining |
US7026443B1 (en) * | 1999-12-10 | 2006-04-11 | Epimmune Inc. | Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions |
JP2001172200A (ja) * | 1999-12-17 | 2001-06-26 | Meneki Seibutsu Kenkyusho:Kk | ヒトナプシンaに対する抗体およびこれを用いる医薬 |
WO2001077142A1 (en) * | 2000-04-05 | 2001-10-18 | Impact Diagnostics, Inc. | Immunological methodology for discerning human papillomavirus |
EP1288292A1 (de) * | 2001-08-31 | 2003-03-05 | Leids Universitair Medisch Centrum | Lange Peptiden die 22-40 Aminosäuren enthalten und die eine immunspezifische Immunantwort induzieren |
AU2002219711B8 (en) * | 2000-12-08 | 2006-03-02 | Academisch Ziekenhuis Leiden | Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
WO2002050537A1 (en) * | 2000-12-21 | 2002-06-27 | Biosignature Diagnostics, Inc. | Absorbance multiplex technology |
US6933123B2 (en) | 2001-04-05 | 2005-08-23 | Yao Xiong Hu | Peptides from the E2, E6, and E7 proteins of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers |
GB2379220A (en) * | 2001-08-13 | 2003-03-05 | Univ York | Antibodies to HPV E2 protein |
JP4647606B2 (ja) * | 2003-09-05 | 2011-03-09 | ジェネンコー・インターナショナル・インク | Hpvcd8+t細胞エピトープ |
JP5030594B2 (ja) * | 2003-12-23 | 2012-09-19 | アルボー ビータ コーポレーション | Hpvの発癌性株に対する抗体およびそれらの使用方法 |
EP1732598A4 (de) * | 2003-12-31 | 2009-08-26 | Pharmexa Inc | Auslösung von zellulären immunantworten gegen den humanen papillovirus unter verwendung von peptid und nucleinsäure-zusammensetzungen |
US7732166B2 (en) * | 2005-11-15 | 2010-06-08 | Oncohealth Corporation | Detection method for human pappilomavirus (HPV) and its application in cervical cancer |
US7972776B2 (en) * | 2005-11-15 | 2011-07-05 | Oncohealth Corporation | Protein chips for HPV detection |
US8051950B2 (en) * | 2006-08-03 | 2011-11-08 | Glacier Bay, Inc. | System for reducing acoustic energy |
US8278056B2 (en) | 2008-06-13 | 2012-10-02 | Oncohealth Corp. | Detection of early stages and late stages HPV infection |
US8968995B2 (en) * | 2008-11-12 | 2015-03-03 | Oncohealth Corp. | Detection, screening, and diagnosis of HPV-associated cancers |
US9562075B2 (en) * | 2007-05-31 | 2017-02-07 | Academisch Ziekenhuis Leiden H.O.D.N. Lumc | Intradermal HPV peptide vaccination |
EP2427763A4 (de) | 2009-05-07 | 2013-08-21 | Oncohealth Corp | Identifikation eines hohen cin2-grades zur erkennung von früh- und spätstadien sowie zum screening und zur diagnose des menschlichen papillomavirus (hpv) und mit diesem assoziierter krebserkrankungen |
EP3311833A3 (de) * | 2009-08-26 | 2018-07-25 | Selecta Biosciences, Inc. | Zusammensetzungen zur induzierung von t-zellen-hilfe |
WO2011085231A2 (en) * | 2010-01-08 | 2011-07-14 | Selecta Biosciences, Inc. | Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines |
JP5819851B2 (ja) | 2010-01-08 | 2015-11-24 | オンコヘルス コーポレーション | Hpv関連の癌の治療及びスクリーニングのための細胞に基づいた高処理能力hpv免疫アッセイ |
CN103940993A (zh) * | 2013-01-23 | 2014-07-23 | 艾托金生物医药(苏州)有限公司 | 用于检测抗人乳头瘤病毒抗体的抗原及试剂盒和应用 |
KR20200022467A (ko) * | 2017-06-28 | 2020-03-03 | 리제너론 파아마슈티컬스, 인크. | 항-인간 유두종 바이러스 (hpv) 항원-결합 단백질 및 그의 사용 방법 |
WO2019145792A1 (en) * | 2018-01-24 | 2019-08-01 | The Council Of The Queensland Institute Of Medical Research | Hpv immunotherapy |
EP3829571A4 (de) | 2018-08-02 | 2022-04-27 | The Board Of Regents Of The University Of Texas System | Adjuvante wirkung des tlr1/2-agonisten diprovocim in synergie mit checkpoint-hemmenden antikörpern zur bekämpfung von krankheiten |
MX2022011765A (es) | 2020-03-26 | 2022-11-09 | Provectus Pharmatech Inc | Usos novedosos de xantenos halogenados en oncologia y virologia. |
US11938182B2 (en) | 2020-03-26 | 2024-03-26 | Provectus Pharmatech, Inc. | Halogenated xanthenes as vaccine adjuvants |
CN112920267B (zh) * | 2021-03-09 | 2021-08-13 | 北京康乐卫士生物技术股份有限公司 | 一种抗人乳头瘤病毒31型的单克隆中和抗体及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4748109A (en) * | 1983-07-01 | 1988-05-31 | Baird Phillip J | Assay method and reagent to determine antibodies to papillomavirus virions |
LU85462A1 (fr) * | 1984-07-11 | 1986-02-12 | Univ Louvain | Nouvelles compositions polymeres,procedes pour leur production et leurs applications |
US4777239A (en) * | 1986-07-10 | 1988-10-11 | The Board Of Trustees Of The Leland Stanford Junior University | Diagnostic peptides of human papilloma virus |
-
1989
- 1989-03-13 US US07/323,614 patent/US5180806A/en not_active Expired - Lifetime
- 1989-05-12 DK DK198902347A patent/DK173264B1/da not_active IP Right Cessation
- 1989-05-15 ES ES89304874T patent/ES2082775T4/es not_active Expired - Lifetime
- 1989-05-15 EP EP89304874A patent/EP0344940B1/de not_active Expired - Lifetime
- 1989-05-15 DE DE68924928T patent/DE68924928T2/de not_active Expired - Lifetime
- 1989-05-15 AT AT89304874T patent/ATE130855T1/de not_active IP Right Cessation
- 1989-05-15 CA CA000599671A patent/CA1341287C/en not_active Expired - Fee Related
- 1989-05-16 PT PT90574A patent/PT90574B/pt not_active IP Right Cessation
- 1989-05-16 JP JP1122691A patent/JP2918904B2/ja not_active Expired - Fee Related
-
1992
- 1992-12-23 US US07/996,027 patent/US5401627A/en not_active Expired - Lifetime
-
1993
- 1993-09-17 US US08/123,465 patent/US5486453A/en not_active Expired - Lifetime
-
1996
- 1996-01-24 GR GR960400172T patent/GR3018773T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK173264B1 (da) | 2000-05-29 |
PT90574A (pt) | 1989-11-30 |
ES2082775T4 (es) | 1996-08-01 |
US5486453A (en) | 1996-01-23 |
DE68924928T2 (de) | 1996-10-17 |
DK234789D0 (da) | 1989-05-12 |
JP2918904B2 (ja) | 1999-07-12 |
JPH0296593A (ja) | 1990-04-09 |
EP0344940A3 (de) | 1991-11-13 |
EP0344940A2 (de) | 1989-12-06 |
PT90574B (pt) | 1994-09-30 |
DE68924928D1 (de) | 1996-01-11 |
DK234789A (da) | 1989-11-17 |
GR3018773T3 (en) | 1996-04-30 |
ES2082775T3 (es) | 1996-04-01 |
CA1341287C (en) | 2001-08-28 |
EP0344940B1 (de) | 1995-11-29 |
US5180806A (en) | 1993-01-19 |
US5401627A (en) | 1995-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE130855T1 (de) | Antikörper gegen latente proteine von menschlichen papillomavirus, diagnostische systeme und methoden. | |
DE69228701T2 (de) | Fragmente von Prion Proteinen. | |
DE59010787D1 (de) | Erythropoietin (EPO)-Peptide und dagegen gerichtete Antikörper | |
FI870447A0 (fi) | Htlv-iii-hoeljepeptider. | |
DK228190D0 (da) | Rajgraespollenallergen | |
DE3872754D1 (de) | Nachweis von antikoerpern humaner immundefizienz-viren. | |
ATE51709T1 (de) | Antigen im zusammenhang mit der fruehzeitigen feststellung von schwangerschaft bei saeugern. | |
ATE119203T1 (de) | Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus. | |
DE69008535T2 (de) | Humane antigammainterferonantikörper, welche detektiert und geklärt sind mit verwendung von synthetischen peptiden. | |
DE69232945T2 (de) | BLUTPLAETTCHEN-GPIIIa P1A1 und -P1A2-EPITOPE, IHRE HERSTELLUNG UND VERWENDUNG | |
DE69028561T2 (de) | Immunoassay zum Nachweis von Antikörpern gegen HIV | |
ATE60445T1 (de) | Verfahren und testelement zum auffinden von zellaesionen. | |
ATE134648T1 (de) | Künstliche polypeptide und antikörper in zusammenhang mit epstein-barr-virus-nuklear- antigen | |
ATE192163T1 (de) | Peptide, analoge und ihre mischungen zur detektion und erzeugung von antikörpern gegen die e1 und e2 proteine des rubella virus | |
FI922710A0 (fi) | Eliminering av aktiverade lymfocyter. | |
MX9707020A (es) | Compuestos y metodos para la deteccion de infeccion por t. cruzi. | |
DE59203874D1 (de) | Schizosaccharomyces-spezifische Polypeptide. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EELA | Cancelled due to lapse of time |